Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004039259 | SCV004892163 | uncertain significance | not specified | 2023-10-05 | criteria provided, single submitter | clinical testing | The c.1720G>A (p.A574T) alteration is located in exon 16 (coding exon 16) of the KEL gene. This alteration results from a G to A substitution at nucleotide position 1720, causing the alanine (A) at amino acid position 574 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Australian Red Cross Blood Service | RCV001543598 | SCV001761658 | affects | Kell blood group system | 2021-07-01 | no assertion criteria provided | research | variable reactions with anti-k antisera. |